Literature DB >> 10196252

Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication.

V Maréchal1, F Arenzana-Seisdedos, J M Heard, O Schwartz.   

Abstract

The alpha-chemokine SDF-1 binds CXCR4, a coreceptor for human immunodeficiency virus type 1 (HIV-1), and inhibits viral entry mediated by this receptor. Since chemokines are potent chemoattractants and activators of leukocytes, we examined whether the stimulation of HIV target cells by SDF-1 affects the replication of virus with different tropisms. We observed that SDF-1 inhibited the entry of X4 strains and increased the infectivity of particles bearing either a CCR5-tropic HIV-1 envelope or a vesicular stomatitis virus G envelope. In contrast to the inhibitory effect of SDF-1 on X4 strains, which is at the level of entry, the stimulatory effect does not involve envelope-receptor interactions or proviral DNA synthesis. Rather, we observed an increased ability of Tat to transactivate the HIV-1 long terminal repeat in the presence of the chemokine. Therefore, the effects of SDF-1 on the HIV-1 life cycle can be multiple and opposite, including both an inhibition of viral entry and a stimulation of proviral gene expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196252      PMCID: PMC104135     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

Review 1.  Chemokines and T lymphocytes: more than an attraction.

Authors:  S G Ward; K Bacon; J Westwick
Journal:  Immunity       Date:  1998-07       Impact factor: 31.745

2.  The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways.

Authors:  R K Ganju; S A Brubaker; J Meyer; P Dutt; Y Yang; S Qin; W Newman; J E Groopman
Journal:  J Biol Chem       Date:  1998-09-04       Impact factor: 5.157

3.  Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1.

Authors:  O Schwartz; V Maréchal; B Friguet; F Arenzana-Seisdedos; J M Heard
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  A new classification for HIV-1.

Authors:  E A Berger; R W Doms; E M Fenyö; B T Korber; D R Littman; J P Moore; Q J Sattentau; H Schuitemaker; J Sodroski; R A Weiss
Journal:  Nature       Date:  1998-01-15       Impact factor: 49.962

5.  The state of maturation of monocytes into macrophages determines the effects of IL-4 and IL-13 on HIV replication.

Authors:  H M Naif; S Li; M Ho-Shon; J M Mathijs; P Williamson; A L Cunningham
Journal:  J Immunol       Date:  1997-01-01       Impact factor: 5.422

6.  HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5.

Authors:  M Farzan; H Choe; K A Martin; Y Sun; M Sidelko; C R Mackay; N P Gerard; J Sodroski; C Gerard
Journal:  J Biol Chem       Date:  1997-03-14       Impact factor: 5.157

Review 7.  Co-receptors for HIV-1 entry.

Authors:  J P Moore; A Trkola; T Dragic
Journal:  Curr Opin Immunol       Date:  1997-08       Impact factor: 7.486

8.  The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.

Authors:  E Oberlin; A Amara; F Bachelerie; C Bessia; J L Virelizier; F Arenzana-Seisdedos; O Schwartz; J M Heard; I Clark-Lewis; D F Legler; M Loetscher; M Baggiolini; B Moser
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

9.  A microtransfection method using the luciferase-encoding reporter gene for the assay of human immunodeficiency virus LTR promoter activity.

Authors:  O Schwartz; J L Virelizier; L Montagnier; U Hazan
Journal:  Gene       Date:  1990-04-16       Impact factor: 3.688

10.  Molecular cloning and structure of a pre-B-cell growth-stimulating factor.

Authors:  T Nagasawa; H Kikutani; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

View more
  17 in total

Review 1.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

2.  CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.

Authors:  S Le Borgne; M Février; C Callebaut; S P Lee; Y Rivière
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Human immunodeficiency virus type 1 (HIV-1)-induced GRO-alpha production stimulates HIV-1 replication in macrophages and T lymphocytes.

Authors:  B R Lane; R M Strieter; M J Coffey; D M Markovitz
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy.

Authors:  B R Lane; K Lore; P J Bock; J Andersson; M J Coffey; R M Strieter; D M Markovitz
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: in vitro studies of mixed virus infections.

Authors:  S Rusconi; S La Seta Catamancio; P Citterio; E Bulgheroni; F Croce; S H Herrmann; R E Offord; M Galli; M S Hirsch
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES.

Authors:  A J Marozsan; V S Torre; M Johnson; S C Ball; J V Cross; D J Templeton; M E Quiñones-Mateu; R E Offord; E J Arts
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  Poly (I:C) and LPS induce distinct immune responses by ovarian stromal fibroblasts.

Authors:  Mickey V Patel; Zheng Shen; Charles R Wira
Journal:  J Reprod Immunol       Date:  2018-05-09       Impact factor: 4.054

8.  Innate immunity in the vagina (Part II): Anti-HIV activity and antiviral content of human vaginal secretions.

Authors:  Mickey V Patel; Mimi Ghosh; John V Fahey; Christina Ochsenbauer; Richard M Rossoll; Charles R Wira
Journal:  Am J Reprod Immunol       Date:  2014-05-08       Impact factor: 3.886

9.  Human uterine natural killer cells but not blood natural killer cells inhibit human immunodeficiency virus type 1 infection by secretion of CXCL12.

Authors:  Teddy F Mselle; Alexandra L Howell; Mimi Ghosh; Charles R Wira; Charles L Sentman
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

10.  G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type 1 isolates.

Authors:  Ali Amara; Aurore Vidy; Genevieve Boulla; Karine Mollier; Javier Garcia-Perez; Jose Alcamí; Cedric Blanpain; Marc Parmentier; Jean-Louis Virelizier; Pierre Charneau; Fernando Arenzana-Seisdedos
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.